Literature DB >> 26846215

Frequencies of EGFR single nucleotide polymorphisms in non-small cell lung cancer patients and healthy individuals in the Republic of Serbia: a preliminary study.

Jasmina Obradović1, Natasa Djordjević2, Natasa Tošic3, Jasminka Mrdjanović4, Biljana Stanković3, Jelena Stanić5, Bojan Zarić5, Branislav Perin5, Sonja Pavlović3, Vladimir Jurišić6.   

Abstract

The purpose of this study was to determine the frequencies of EGFR -216G>T, -191C>A, and 181946C>T in Serbian non-small cell lung cancer (NSCLC) patients, as well as to compare it with healthy individuals, in order to assess their potential importance for lung cancer in Serbia. The study involved 56 NSCLC patients and 53 unrelated healthy volunteers, and genotyping was performed on DNA samples obtained from formalin-fixed paraffin-embedded lung tumor tissue and blood, respectively. This was the first time to show genotype frequencies of those single nucleotide polymorphisms for this study group from the territory of the Republic of Serbia. There was very strong evidence of association between age and death due to lung cancer (Pearson chi-square = 43.439, df = 2, p < 0,001), as well as between ever smoking and death due to lung cancer (Pearson chi-square = 31.727, df = 1, p < 0.001). When dominant genetic model (GG vs. GT+TT) was used for -216G>T, we have found significant association (p = 0.012) between -216GG genotype and NSCLC patients within smokers' subgroup. So, carriers of -216GG genotype had higher risk (OR = 4.33, 95 % CI = 1.324-14.179) than noncarriers (GT and TT) for developing non-small cell lung cancer in our patients.

Entities:  

Keywords:  Epidermal growth factor receptor; Non-small cell lung cancer; Single nucleotide polymorphism

Mesh:

Substances:

Year:  2016        PMID: 26846215     DOI: 10.1007/s13277-016-4930-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  39 in total

Review 1.  Mutations of the epidermal growth factor receptor in non-small cell lung cancer -- search and destroy.

Authors:  S K Chan; W J Gullick; M E Hill
Journal:  Eur J Cancer       Date:  2006-01       Impact factor: 9.162

2.  Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.

Authors:  Christopher I Amos; Xifeng Wu; Peter Broderick; Ivan P Gorlov; Jian Gu; Timothy Eisen; Qiong Dong; Qing Zhang; Xiangjun Gu; Jayaram Vijayakrishnan; Kate Sullivan; Athena Matakidou; Yufei Wang; Gordon Mills; Kimberly Doheny; Ya-Yu Tsai; Wei Vivien Chen; Sanjay Shete; Margaret R Spitz; Richard S Houlston
Journal:  Nat Genet       Date:  2008-04-02       Impact factor: 38.330

3.  The impact of epidermal growth factor receptor gene status on gefitinib-treated Japanese patients with non-small-cell lung cancer.

Authors:  Shuji Ichihara; Shinichi Toyooka; Yoshiro Fujiwara; Katsuyuki Hotta; Hisayuki Shigematsu; Masaki Tokumo; Junichi Soh; Hiroaki Asano; Kouichi Ichimura; Keisuke Aoe; Motoi Aoe; Katsuyuki Kiura; Kenji Shimizu; Hiroshi Date; Nobuyoshi Shimizu
Journal:  Int J Cancer       Date:  2007-03-15       Impact factor: 7.396

4.  Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib.

Authors:  G Liu; S Gurubhagavatula; W Zhou; Z Wang; B Y Yeap; K Asomaning; L Su; R Heist; T J Lynch; D C Christiani
Journal:  Pharmacogenomics J       Date:  2007-03-20       Impact factor: 3.550

5.  A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter.

Authors:  Wanqing Liu; Federico Innocenti; Michael H Wu; Apurva A Desai; M Eileen Dolan; Edwin H Cook; Mark J Ratain
Journal:  Cancer Res       Date:  2005-01-01       Impact factor: 12.701

Review 6.  Pharmacogenetics, pharmacogenomics, and individualized medicine.

Authors:  Qiang Ma; Anthony Y H Lu
Journal:  Pharmacol Rev       Date:  2011-03-24       Impact factor: 25.468

7.  Epidermal growth factor (EGF) receptor gene transcription. Requirement for Sp1 and an EGF receptor-specific factor.

Authors:  R Kageyama; G T Merlino; I Pastan
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

8.  Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with Gefitinib.

Authors:  Fei Ma; Tong Sun; Yuankai Shi; Dianke Yu; Wen Tan; Ming Yang; Chen Wu; Datong Chu; Yan Sun; Binghe Xu; Dongxin Lin
Journal:  Lung Cancer       Date:  2009-02-06       Impact factor: 5.705

Review 9.  East meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians.

Authors:  Wei Zhou; David C Christiani
Journal:  Chin J Cancer       Date:  2011-05

10.  Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer: a case-control study.

Authors:  Jin Eun Choi; Sun Ha Park; Kyung Mee Kim; Won Kee Lee; Sin Kam; Sung Ick Cha; Chang Ho Kim; Young Mo Kang; Young-Chul Kim; Sung Beom Han; Tae Hoon Jung; Jae Yong Park
Journal:  BMC Cancer       Date:  2007-10-24       Impact factor: 4.430

View more
  2 in total

Review 1.  Application of molecular targeted therapies in the treatment of head and neck squamous cell carcinoma.

Authors:  Paulina Kozakiewicz; Ludmiła Grzybowska-Szatkowska
Journal:  Oncol Lett       Date:  2018-03-20       Impact factor: 2.967

Review 2.  Epidermal Growth Factor Receptor Gene in Non-Small-Cell Lung Cancer: The Importance of Promoter Polymorphism Investigation.

Authors:  Vladimir Jurišić; Jasmina Obradovic; Sonja Pavlović; Nataša Djordjevic
Journal:  Anal Cell Pathol (Amst)       Date:  2018-10-14       Impact factor: 2.916

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.